<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00836771</url>
  </required_header>
  <id_info>
    <org_study_id>80801</org_study_id>
    <nct_id>NCT00836771</nct_id>
  </id_info>
  <brief_title>Infant Formula Supplemented With Probiotic Microorganisms and/or Prebiotic.</brief_title>
  <official_title>Evaluation of the Effect of Milk Based Infant Formula Supplemented Either With Probiotic Microorganisms and/or With Prebiotic on the Intestinal Microflora During the First 4 Months of Life of Healthy, Full Term Infants and it's Long Term Effect on Morbidity up to the Age of 9 Months</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Materna Laboratories</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Materna Laboratories</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation the nutritional suitability of a based milk infant formula supplemented with
      friendly bacteria (probiotic microorganisms) and or nutritional fibers (prebiotic) to
      healthy, full term infants compare with an otherwise identical widely used commercially
      available milk based infant formula and/or breast feed
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>weight gain</measure>
    <time_frame>1 to 120 days of age</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anthropometric</measure>
    <time_frame>1-120 days of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GI tolerance</measure>
    <time_frame>1-120 days of age</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Influence on the microbial content of the stool</measure>
    <time_frame>3 - 4 times: 1-16 d, 4 w 16 w and 36 w</time_frame>
    <description>Stool were collected to analyze the microbial content of certain bacteria upon enrollment and at the age of 4, 16. and 36 w Stool were collected and delivery to the lab in coolers within 12 h</description>
  </other_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">270</enrollment>
  <condition>Focus on Healthy Infant Growth.</condition>
  <arm_group>
    <arm_group_label>Materna infant formula 1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>milk based infant formula powder</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Materna infant formula 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Probiotic supplemented infant formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Materna infant formula 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prebiotic supplemented infant formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Materna infant formula 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prebiotic+ Probiotic supplemented infant formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Human milk</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Human Milk</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Infant Formula</intervention_name>
    <arm_group_label>Materna infant formula 1</arm_group_label>
    <arm_group_label>Materna infant formula 2</arm_group_label>
    <arm_group_label>Materna infant formula 3</arm_group_label>
    <arm_group_label>Materna infant formula 4</arm_group_label>
    <arm_group_label>Human milk</arm_group_label>
    <other_name>Materna</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy term infants of both sexes, born in natural labor .

          -  Single birth.

          -  Full term infants (born between the 37th and 42nd week of gestation)

          -  Infants with birth weight &gt;2500 g.

          -  Recruitment age will be 0-21 days.

          -  Infants whose mothers are unable to breast feed or have chosen not to breast feed
             prior to the study enrollment.

          -  Infants whose parents have agreed to participate in the study up to the age of 9
             months..

          -  Infants whose parents have agreed to remain exclusively on the same product for 16
             weeks of age..

          -  Infants whose parents have signed the informed consent form.

          -  Infants whose parents are able to understand the protocol requirements and to fill out
             the infant's diary and agree to completely fill out the parents' questionnaires during
             the period Of 9 months

        Exclusion Criteria:

          -  Twins.

          -  Premature or low birth weight (&lt; 2500 g).

          -  Chromosomal abnormalities or congenital malformation.

          -  Suffering jaundice which require phototherapy.

          -  Proven or suspected family history of allergy to cow's milk.

          -  Having been treated with antibiotics or other drugs during the last three days or more
             prior to the commencement of the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>21 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nehama Linder, M.D. Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neonatology department, Rabin Medical center, Petach Tikva. Israel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Raanan Shamir, M.D. Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Gastroenterology Nutrition and Liver Diseases Schneider children medical center, Petach Tikva.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kobi Shiff, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neonatology department, Laniado Hospital- Sanz Medical Center, Netanya, Israel.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zvi Weizman, M.D. Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pediatrics, Soroka University Medical Center, Beer-Sheva, Israel.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Uri Rubenstein, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>clinic, 1 Yehuda Perach St., Natanya</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Neonatology department, Laniado Hospital- Sanz Medical Center, .</name>
      <address>
        <city>Netanya,</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2009</study_first_submitted>
  <study_first_submitted_qc>February 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2009</study_first_posted>
  <last_update_submitted>July 30, 2013</last_update_submitted>
  <last_update_submitted_qc>July 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 31, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Infant formula</keyword>
  <keyword>Probiotic microorganisms</keyword>
  <keyword>prebiotic</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

